ZURICH (Reuters) – Roche is launching a SARS-CoV-2 variant test to help monitor emerging coronavirus mutations, the Swiss pharmaceuticals group said on Tuesday. The test runs on widely used high-throughput systems and is for research purposes only.
“Periodic assessments against emerging variants have shown that Roche’s current diagnostic tests for detecting active SARS-CoV-2 infections remain accurate and effective,” it said.
The new SARS-CoV-2 Variant Set 1 Test is designed to detect and differentiate mutations found in variants that originated in the UK (B.1.1.7), South Africa (B.1.351), and Brazil (P.1), the company said in its announcement (https://bit.ly/3bRZTmr).
Source: Read Full Article